Table 1.
Baseline characteristic | COVID-19 | Non-COVID-19 | Full sample | |||
---|---|---|---|---|---|---|
n | % | n | % | N | % | |
Gender | ||||||
Female | 3 | 42.9 | 3 | 37.5 | 6 | 40 |
Male | 4 | 57.1 | 5 | 62.5 | 9 | 60 |
Co-morbidity | ||||||
DM | 3 | 42.9 | 3 | 37.5 | 6 | 40 |
HT | 3 | 42.9 | 2 | 25.0 | 5 | 33.3 |
COPD | 3 | 42.9 | - | - | 3 | 20 |
Cardiomyopathy | - | - | 1 | 12.5 | 1 | 6.7 |
None | 2 | 28.6 | 3 | 37.5 | 5 | 33.3 |
Symptom | ||||||
Dyspnea | 2 | 28.6 | 4 | 50 | 6 | 40 |
Stridor | 3 | 42.9 | 3 | 37.5 | 6 | 40 |
Inability to wean tracheostomy | 2 | 28.6 | 1 | 12.5 | 3 | 20 |
IMV etiology | ||||||
RDS due to COVID-19 | 7 | 100 | - | - | 7 | 46.6 |
SAH | - | - | 2 | 25 | 2 | 13.3 |
CVA | - | - | 2 | 25 | 2 | 13.3 |
CCHF | - | - | 1 | 12.5 | 1 | 6.7 |
Drug intoxication | - | - | 1 | 12.5 | 1 | 6.7 |
Hearth failure | - | - | 1 | 12.5 | 1 | 6.7 |
Pneumonia after CABG | - | - | 1 | 12.5 | 1 | 6.7 |
Tracheostomy | ||||||
None | 4 | 57.1 | 5 | 62.5 | 9 | 60 |
Prolonged IMV | 1 | 14.3 | 2 | 25.0 | 3 | 20 |
Urgent | 2 | 28.6 | 1 | 12.5 | 3 | 20 |
Participants were on average 43.3 years old (SD = 20.5)
DM diabetes mellitus, HT hypertension, COPD chronic obstructive pulmonary disease, IMV invasive mechanical ventilation, RDS respiratory distress syndrome, SAH subarachnoid hemorrhage, CVA cerebro vascular accident, CCHF Crimean-Congo hemorrhagic fever, CABG coronary artery by-pass grafting surgery